Skip to main content

Squarepoint Ops LLC

Position in TGTX — Tg Therapeutics, Inc.

CIK 1642575 NEW YORK, NY

Position in TGTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$9,173,606
-$7,895,261 QoQ
Shares Held
166,975
-67.5% QoQ
Ownership
0.109%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#73
of 426 holders
Holding Since
Mar 2020
17 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in TGTX Over Time

Shares Held

Position Value (USD)

Derivatives in TGTX

reported options exposure · as of Jun 30, 2026
CallValue
$3,060,158
CallShares
55,700
PutValue
$6,444,462
PutShares
117,300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Squarepoint Ops LLC holds $1,238,596,915 across 255 Biotechnology names. TGTX ranks #34 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in TGTX

Export CSV
27 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,060,158 55,700
2026-06-30 $9,173,606 166,975
2026-06-30 $6,444,462 117,300
2026-03-31 $17,068,867 513,813
2025-12-31 $25,413,680 852,522
2025-12-31 $208,670 7,000
2025-09-30 $498,525 13,800
2025-09-30 $317,900 8,800
2025-09-30 $18,229,903 504,634
2025-06-30 $525,454 14,600
2025-06-30 $406,687 11,300
2025-03-31 $461,331 11,700
2025-03-31 $12,587,081 319,226
2025-03-31 $579,621 14,700
2024-12-31 $1,799,980 59,800
2024-12-31 $6,344,929 210,795
2024-12-31 $1,486,940 49,400
2024-09-30 $1,139,397 48,713
2024-06-30 $919,938 51,711
2024-03-31 $932,129 61,284
2023-12-31 $5,565,073 325,824
2023-09-30 $594,187 71,075
2023-03-31 $1,010,372 67,179
2022-12-31 $983,463 83,133
2022-09-30 $687,536 116,138
2021-12-31 $252,301 13,279
2020-03-31 $724,125 73,590